biotech / news / / Free Press Journal
Pfizer Limited reported a 40 percent year-on-year decline in net profit to ₹199.8 crore in Q4 FY26.
Pfizer Limited's Q4 FY26 net profit fell 40% year-on-year to ₹199.8 crore.
KEY POINTS
- Sequential net profit rose 41% from Q3 FY26, aided by lower exceptional charges and reduced expenses.
- Pfizer incurred exceptional charges of ₹49.2 crore in FY26 due to personnel separation costs tied to Cipla.
- Employee benefits expense dropped to ₹77.2 crore in Q4 FY26 from ₹82.9 crore last year.
- Pfizer's board recommended a final dividend of ₹75 per equity share, totaling ₹343.1 crore.
COMPANIES
Summarized by Newsio from Free Press Journal. How we summarize →